Crescendo Aims To Increase IO Share Of Voice With Humabody Platform

 
• By Mike Ward
  
Peter Pack
Peter Pack, CEO of Crescendo Biologics, talks to Scrip at BIO-Europe Spring 2018 • Source: Scrip/LEllis

More from Immuno-oncology

More from Anticancer